Lorazepam dose-dependently decreases risk-taking related activation in limbic areas

Author: Arce Estibaliz   Miller Daniel   Feinstein Justin   Stein Murray   Paulus Martin  

Publisher: Springer Publishing Company

ISSN: 0033-3158

Source: Psychopharmacology, Vol.189, Iss.1, 2006-11, pp. : 105-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next